CLINICAL_TRIALS ClinicalTrials.gov record update

Contribution of the Integrase Inhibitor Dolutegravir to Obesity and Cardiovascular Disease in Persons Living With HIV

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04340388
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:02.925940+00:00
Published At: 2023-07-27T00:00:00+00:00
Record Updated At: 2023-07-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["HIV-1-infection", "Antiviral Drug Adverse Reaction", "Vascular Diseases", "Cardiovascular Abnormalities", "Abnormality of Adipose Tissue", "Body Weight Changes", "Body Fat Disorder", "HIV-Associated Lipodystrophy Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-07-27"
protocolSection.identificationModule.nctId: "NCT04340388"
protocolSection.identificationModule.officialTitle: "Contribution of the Integrase Inhibitor Dolutegravir to Obesity and Cardiovascular Disease in Persons Living With HIV"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.